Cytisine

Cytisine has been studied in 15 papers since 2025: 4 observational studies in people, 1 in animals, 8 reviews; 14 in the past year. The newest paper, Nov 8, 2026: “Cytisine for Smoking Cessation: A Narrative Review of an Underutilized Therapy”.

Intervention

15 papers study it1 more mentions it11 findingsUpdated

PubChemChEBIMeSH

2 new papers in 30 daysSee all 16 papers on cytisine

At a glance

The findings reach people, from one lab or study. 3 independent labs in 3 countries; 21 trials, none about aging, 7 with no results posted.

“The smoking cessation rate was 50.1% among cytisine users versus 8.1% for those receiving counseling alone (n = 2173) (p <0.05), adjusted OR: 14.53 (95% confidence interval [CI]: 11.67-18.08).”
Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2026doi:10.1016/j.jtho.2026.104071

None of its findings points the other way.

Cells and humans: a single group. Worms or flies and mice: nothing yet.
  • 3 independent labs in 3 countries
  • 21 trials, none about aging, 7 with no results posted
  • Funders: Istituti di Ricovero e Cura a Carattere Scientifico and 3 more
  • 13 of 21 trials sponsored by its developers
  • Humans4
  • Animals1
  • In silico1

What did studies of cytisine find?

7

Studies of cytisine measured 7 outcomes; the most studied is smoking cessation (3 studies).

Smoking cessation

upin humans2upin reviews1

3 studies
  1. Cytisine increases smoking cessation in humans (Compared with placebo).

    “Randomized trials show that cytisine has greater smoking-cessation efficacy than placebo.”

    ReviewCompared with placebo

    Cytisine for Smoking Cessation: A Narrative Review of an Underutilized Therapy

    Pulmonary therapy

  2. Cytisine improves smoking cessation in humans.

    “Two Phase 3 randomized double-blind placebo-controlled trials have demonstrated cytisinicline's efficacy and safety for smoking cessation in US adults.”

    Review

    An evaluation of cytisinicline for smoking cessation in adult smokers

    Expert opinion on pharmacotherapy

  3. Cytisine improves smoking cessation (early trials).

    “Cytisine, a plant-derived partial nicotinic agonist, has shown effectiveness in early trials and may offer a favorable tolerability and cost profile.”

    Reviewearly trials

    Emerging and Established Pharmacotherapies for Smoking Cessation: A Review

    Cardiology in review

Cigarette consumption

downin humans1

1 study
  1. Cytisine decreases cigarette consumption in humans (vs counseling alone) (23.4% versus 10.0%).

    “The cytisine group reported a greater reduction in cigarette consumption (23.4% versus 10.0%, p <0.0001).”

    Human trialvs counseling alone1.5 mg on an escalating and deescalating schedulen = 3,548

    Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP Trial

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Smoking abstinence

upin humans1OR 14.53

1 study
  1. Cytisine increases smoking abstinence in humans within lung cancer screening, vs counseling alone (OR 14.53 (95% CI 11.67-18.08)).

    “The smoking cessation rate was 50.1% among cytisine users versus 8.1% for those receiving counseling alone (n = 2173) (p <0.05), adjusted OR: 14.53 (95% confidence interval [CI]: 11.67-18.08).”

    Human trialwithin lung cancer screening, vs counseling alone1.5 mg on an escalating and deescalating schedulen = 3,548

    Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP Trial

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Dyspnea

upin humans1

1 study
  1. Cytisine is linked with better dyspnea in humans.

    “Improvement in dyspnea was reported more frequently among cytisine users.”

    Humansn = 113

    Real-world effectiveness of cytisine, bupropion, and nicotine replacement therapy in a smoking cessation clinic: A single-center retrospective cohort study

    Tobacco induced diseases

Years of life lost

downin silico1−11%

1 study
  1. Cytisine decreases years of life lost in silico (-10.9%).

    “In a scenario including the transition probabilities from the TTP cohort, this alternative would result in a 10.9% reduction in YLL”

    In silico

    Markov-model cost-effectiveness evaluation of a cessation programme when tobacco policies are comprehensive

    BMJ open

Smoking

downin humans1

1 study
  1. Cytisine decreases smoking in humans.

    “Owing to its efficacy, tolerability profile, and low cost, cytisine represents a valuable addition to the smoking cessation toolkit.”

    Review

    Rediscovering cytisine: Why the WHO's decision matters for global public health

    iScience

More on Smoking

CHRNA3

upin mouse cells1

1 study
  1. Cytisine increases CHRNA3 in mouse cells.

    “nicotine and cytisine increased it”

    CellsHT22 cells

    The Cholinergic Receptor Nicotinic α3 Was Reduced in the Hippocampus of Early Cognitively Impaired Adult Male Mice and Upregulated by Nicotine and Cytisine in HT22 Cells

    Cells

More on CHRNA3

What is cytisine linked with?

2

Studies link cytisine with 2 measures: reported adverse events and smoking cessation.

Reported adverse events

downin humans1

1 study
  1. Cytisine is associated with reported adverse events in humans (Compared with varenicline in direct comparative trials).

    “Cytisine is generally well tolerated and has been associated with fewer reported adverse events than varenicline in direct comparative trials.”

    ReviewCompared with varenicline in direct comparative trials

    Cytisine for Smoking Cessation: A Narrative Review of an Underutilized Therapy

    Pulmonary therapy

Smoking cessation

upin humans1

1 study
  1. Cytisine is associated with smoking cessation in humans (58.2% vs 39.1%, p=0.046).

    “Cytisine use was more frequent among patients who achieved smoking cessation (58.2% vs 39.1%, p=0.046)”

    Humansn = 113

    Real-world effectiveness of cytisine, bupropion, and nicotine replacement therapy in a smoking cessation clinic: A single-center retrospective cohort study

    Tobacco induced diseases

Has cytisine been tested in people?

0 of 21 about aging

Yes: 4 observational studies in people have been published, and 20 trials are registered.

In trials

All 9

Who is developing cytisine?

1 company: Achieve Life Sciences.

Companies
  • Achieve Life SciencesPhase 3smoking cessation, vaping cessation

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 2Feb 2026: 3Mar 2026: 5Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 1Sep 2026: 1Oct 2026: 0Nov 2026: 215 papers in 12 months

See all 16 papers on cytisine